EXECUTIVE ENGAGEMENTS
OUTREACH
8867
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1241
Interactions with Platform & by Email
PARTICIPANTS
266
Unique # Participated
VALIDATIONS
121
Responses Validated*
COMPETITORS
31
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
32
PAGES
93
EDITION
17
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027.
The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
SELECT PLAYERS
Abbott Laboratories; Allergan Plc; Bayer AG; Novartis AG; Noven Pharmaceuticals Inc.; Novo Nordisk A/S; Pfizer Inc.; TherapeuticsMD Inc.
SEGMENTS
» Segment (Hormone Replacement Therapy (HRT))
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| An Introduction to Menopause and Hormone Replacement Therapy |
| Recent Market Activity |
| The HRT Controversy - An Insight |
| Newer Studies Challenge WHI Findings and Re-establish Safety of HRT |
| Revised Recommendations of the NAMS and Endocrine Society |
| IMS Consensus Guidelines Paving Way for More Clarity of HRT |
| The Regional Divide |
| Increasing Number of Menopausal Women - A Major Market Driver |
| New Bioidentical Drugs Serve Unmet Market Needs |
| Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions |
| Intense Competition Marks the Global HRT Market |
| The Premarin Saga |
| Estrace Cream Drives Revenue Gains in Allergan’s HRT Portfolio |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Laboratories (USA) |
| Allergan Plc (Ireland) |
| Bayer AG (Germany) |
| Noven Pharmaceuticals, Inc. (USA) |
| Novartis AG(Switzerland) |
| Novo Nordisk A/S (Denmark) |
| Orion Pharma AB (Finland) |
| Pfizer, Inc. (USA) |
| TherapeuticsMD, Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Unmet Needs in Combination Therapies for HRT drive Research for New Medicines |
| Topical Estrogens - More Safe and Effective |
| Transdermal HRT Products Present Exciting Opportunities |
| Phytoestrogens - The New Panacea for Menopausal Symptoms? |
| Diet Link to Menopause Symptoms Raises Interest |
| Impact of Soy and Other Phytoestrogens - A Reality Check |
| EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms |
| The Growing Buzz around Bioidentical Drugs |
| Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT? |
| Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT |
| Direct-to-Consumer Advertising for HRT - A Mixed Bag |
| Estriol: The Next Generation Estrogen Therapy? |
| What Makes Estriol Work? |
| Topical Estriol - More Promising in Safety |
| Estriol - Used More Commonly Outside the US |
| Entry of Generics Threatens Market Growth Prospects |
| Are Non-Hormonal Therapies A Threat to HRT? |
| Earlier Failures Induce Lethargy in Non-Hormonal Therapies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| CANADA |
| Canada Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| JAPAN |
| Japan Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| CHINA |
| China Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| EUROPE |
| Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| GERMANY |
| Germany Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| ITALY |
| Italy Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UNITED KINGDOM |
| UK Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Segment - Hormone Replacement Therapy (HRT) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| IV. COMPETITION |
| Total Companies Profiled: 31 |
The World of Hormone Replacement Therapy (HRT) is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com